High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored?

    loading  Checking for direct PDF access through Ovid


The accumulation of immunosuppressive cells and exhausted effector T cells highlight an important immune dysfunction in advanced stage hepatocellular carcinoma (HCC) patients. These cells significantly hamper the efficacy of immunotherapies and facilitate HCC progression. We have recently demonstrated that the multipronged depletion of immunosuppressive cells potentially restores effector T-cell function in HCC.

Related Topics

    loading  Loading Related Articles